ERBB2 and breast carcinoma: Despite the known prognostic factors for breast cancer, including tumor size, nodal involvement, grade, lymphovascular invasion, and the estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) statuses [2], relapse is still difficult to predict.